ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 048

Clinical characteristics of childhood-onset primary Sjögren’s syndrome in South Korea: two centers’ experiences

Seon Hee Lim1 and Seong Heon Kim2, 1Pusan National University Children's Hospital, 2Seoul National University Children’s Hospital

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Clinical and Therapeutic Aspects I

Session Time: 6:00PM-7:00PM

Background/Purpose: Sjögren’s syndrome is a chronic autoimmune disease that involved the exocrine glands, and primary Sjögren’s syndrome occurs rarely in children and adolescents. It is known that exocrine gland invasions such as dry eye or dry mouth decrease quality of life and increase the risk of malignancy in long term outcomes, so regular follow-up is necessary. Therefore, we aimed to identify in clinical features of primary childhood Sjögren’s syndrome in South Korea to help with diagnosis and treatment.

Methods: We retrospectively analyzed with childhood-onset primary Sjögren’s syndrome underage of 20 years from 2008 to 2024. Data from patients who occurred at Seoul National University Children’s Hospital and Pusan National University Children’s Hospital were collected through electronic medical records.

Results: A total of 20 patients, comprising 5 males and 15 females, exhibited a sex ratio of 1:3. The age at diagnosis was 14.2±2.5 years, and the age at last follow-up was 18.3±4.0 years. The total observation period was 48.0±42.1 months. Among the accompanying symptoms at the time of diagnosis, inflammatory reactions such as fever were the most common at 70%, followed by sialadenitis at 45%, and dry mouth, musculoskeletal involvement, and skin involvement at 40% respectively. In the early-onset group, parotitis was a prevalent symptom, whereas xerophthalmia was more common in the late-onset group. All patients fulfilled the 1999 proposed criteria for jSS and 2018 Japanese criteria, but only 15% met the 2016 ACR/EULAR criteria. Pharmacological treatment was administered to 85% of patients, with hydroxychloroquine and corticosteroids bed the primary medication used. At the last follow-up, improvements in inflammatory markers and ESSDAI scores were observed, with the initial low-ESSDAI group demonstrating lower final ESSDAI scores. During the follow-up period, one patients was diagnosed with dermatofibrosarcoma.

Conclusion: The clinical symptoms of childhood-onset primary Sjögren’s syndrome are different from those in adults. Even if they do not initially meet the diagnostic criteria, regular follow-up was necessary, and appropriate treatment should be provided. Additional multicenter studies will be important to understand the characteristics of childhood-onset primary Sjögren’s syndrome.


Disclosures: S. Lim: None; S. Kim: None.

To cite this abstract in AMA style:

Lim S, Kim S. Clinical characteristics of childhood-onset primary Sjögren’s syndrome in South Korea: two centers’ experiences [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/clinical-characteristics-of-childhood-onset-primary-sjogrens-syndrome-in-south-korea-two-centers-experiences/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-of-childhood-onset-primary-sjogrens-syndrome-in-south-korea-two-centers-experiences/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology